MedRhythms has announced the introduction of a new reimbursement code by the US Centers for Medicare and Medicaid Services (CMS) for its InTandem rehabilitation system.
The newly allocated HCPCS code, E3200, categorises InTandem as a “gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only.” The code will come into effect from October 2024.
The classification places InTandem within Medicare’s durable medical equipment (DME) benefit category, acknowledging its durability and suitability for home use.
The decision by CMS to issue this new code addresses the persistent challenge of accessing rehabilitation services for chronic stroke patients once they have returned home. The new code aims to overcome a significant barrier for these patients, who frequently face difficulties in obtaining effective rehabilitation after being discharged from clinical settings.
MedRhythms co-founder and CEO Brian Harris said: “As a clinician, I am acutely aware of the difficulties stroke patients encounter in accessing treatment during the chronic phase of recovery. The issuance of this HCPCS code provides renewed hope for patients struggling with walking deficits and supports MedRhythms’ commitment to delivering accessible, effective care.”
InTandem is designed to deliver rhythmic auditory stimulation (RAS) therapy in a home environment.
The system includes wearable, clinical-grade gait sensors and a hardware control unit that utilises adaptive algorithms and clinically optimised music to provide therapy. This approach aims to improve gait quality and speed, focusing on principles such as individualisation, progression, and challenge to enhance health outcomes for post-stroke patients.
The InTandem system was granted breakthrough device designation by the US Food and Drug Administration (FDA) in 2020. Listed subsequently as a Class II medical device in July 2023, intended for use in improving walking and ambulation in individuals with chronic stroke.
The system is designed for home use to support the physical rehabilitation of ambulatory adults.
